Track #3: Viral Hepatitis C

Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

This session emphasizes on:

• Recent Advances in Hepatitis C therapy

• Prevention of HCV reinfection

• HCV: Direct Acting Antiviral Era

• Hepatitis C: Epidemiology

• HCV Kinetic Models and Implications in Drug Development

• Treatment options in patients who failed DAA regimens 

Submit your abstract and Register Now and avail Early-Bird benefits!!!